MMD

NYLI MacKay DefinedTerm Muni Opportunities Fund

NYSE · CIK 0001518557
$15.17 -0.72%
Vol
Inst. Holders3 funds
Inst. Value$15.6M
Inst. Activity0 buys / 1 sells
Exchange NYSE·CIK 0001518557·Prev Close $15.28

Recent Activity

Inst.
UBS Group AG — TRIM
70,378 shares ($1.1M)
Inst.
WELLS FARGO & COMPANY/MN — ADD
299,810 shares ($4.5M)

Top Institutional Holders

FundValueMove
MORGAN STANLEY$6.9MTRIM
BANK OF AMERICA CORP$4.8M
WELLS FARGO & COMPANY/MN$3.8MADD
3 institutional holders with $15.6M total value (1,046,654 shares) as of 2025-Q4. Top holders: MORGAN, BANK, WELLS.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1MORGAN STANLEY467,318$6.9M44.6%TRIM -33.6%
2BANK OF AMERICA CORP /DE/323,190$4.8M30.9%
3WELLS FARGO & COMPANY/MN256,146$3.8M24.5%ADD +25.8%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
UBS Group AGTRIM105,54070,378-33.3%$1.1M2025-Q3
WELLS FARGO & COMPANY/MNADD238,404299,810+25.8%$4.5M2025-Q1
UBS Group AGTRIM166,577113,320-32.0%$1.7M2025-Q1
MORGAN STANLEYTRIM814,093540,641-33.6%$8.1M2024-Q4
UBS Group AGADD115,290166,577+44.5%$2.5M2024-Q4
CITADEL ADVISORS LLCEXIT12,3090-100.0%$0.002024-Q4

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.